CGT

37개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved37 programs
CGTLimited DatastaleBinhui Biopharmaceutical Co., L…Phase 1

IDOV-SAFETM (Oncolytic Virus injection, Oncolytic Virus injection(IDOV-SAFETM))

Neoplasms · Neoplasms

#Neoplasms#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 59Status Recruiting
CGTLimited DatastaleAllife Medical Science and Tech…Phase 1

CRISPR/Cas9 (CRISPR/Cas9)

Human Papillomavirus-Related Malignant Neoplasm · Human Papillomavirus-Related Malignant N

#HumanPapillomavirus-RelatedMalig#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 50Status Active
CGTLimited DatastaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 1

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 35Status Recruiting
CGTLimited DatastaleTaizhou HoudeAoke Biomedical Co…Phase 1

OH2 oncolytic virus (OH2 oncolytic virus)

Digestive System Neoplasms · Digestive System Neoplasms

#DigestiveSystemNeoplasms#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 14Status Active
CGTLimited DatastaleChongqing University Cancer Hos…Phase 2

Oncolytic Virus H101 (Oncolytic Virus H101)

Rectal Neoplasms; Rectal Adenocarcinoma · Rectal Neoplasms

#RectalNeoplasms#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 10Status Recruiting
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 2

MB-CART2019.1 (zamtocabtagene autoleucel, zamtocabtagene autoleucel (MB-CART2019.1))

Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B Cell Lymphoma · B-Cell Neoplasm

#B-CellNeoplasm#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 10Status Recruiting
CGTLimited DatastaleSichuan UniversityPhase 1

EpCAM CAR-T cells (EpCAM CAR-T cells)

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M); Breast Cancer Recurrent · Malignant Neoplasm of Nasopharynx TNM St

#MalignantNeoplasmofNasopharynxTN#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 7Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

CD123 targeted CAR-NK cells (CD123 targeted CAR-NK cells)

Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 4Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

AML (Acute Myeloid Leukemia); BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) · AML (Acute Myeloid Leukemia)

#AMLAcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleUTC Therapeutics Inc.Phase 1

Anti-CD70 CAR-T cells (Anti-CD70 CAR-T cells)

Renal Cell Carcinoma · CD70-positive Advanced Urologic Neoplasm

#CD70-positiveAdvancedUrologicNeo#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
CGTLimited DatastaleRobbie MajznerPhase 1

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

Central Nervous System Neoplasms; Brain Tumor · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleBristol-Myers SquibbPhase 1

IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells)

Metastatic Malignant Solid Neoplasm; Metastatic Melanoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

BCMA targeted prime CAR-T cells (BCMA targeted prime CAR-T cells)

Multiple Myeloma; Neoplasm, Plasma Cell · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleThe General Hospital of Western…Phase 1

CAR 70-BCMA CAR-T (CAR 70-BCMA CAR-T)

Relapsed or Refractory Plasma Cell Neoplasms · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 1

CAR BCMA-CD70-T cells (CAR BCMA-CD70-T cells)

High-risk Plasma Cell Neoplasms · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 1

CAR19BCMA-T cells (CAR19BCMA-T cells)

Relapsed or Refractory Plasma Cell Neoplasms; Lymphomas/Leukemias With Plasmacytic Differentiation · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting

1 / 2 pages

← PreviousNext →